Welcome and introduction (ID 1231)
The role of KRAS as a molecular driver in advanced NSCLC and mCRC (ID 1232)
Changing the course for KRAS-mutated advanced NSCLC (ID 1233)
Changing the course for KRAS-mutated metastatic CRC (ID 1234)
Panel discussion (ID 1235)
